Murine erythroleukemia cells are virus-transformed erythroid precursors approximating the CFUe stage of normal erythroid differentiation. On exposure to any of a variety of inducing chemicals, they initiate a coordinated program of gene expression and cell growth characteristic of this precursor. These projects have as their aim the elucidation of factors regulating the coordinated expression of genes on different chromosomes which control characteristics of induced erythroid cell differentiation including terminal cell division and globin gene expression. Three broad objectives are defined: (1) to study alterations in DNA and chromatin structure that accompany induced differentiation and examination of their role in regulating globin gene expression, including establishment of the transcription-competent state and initiation of transcription employing molecular biological probes of chromatin and DNA configuration. Current progress includes definition of the nuclease-sensitive domain and its relationship to chromatin proteins and the analysis of chain termination signals; (2) to study the relationship between gene replication and induced transcription including the identification, isolation, and location of globin gene-associated origins of replication and other regulatory sequences; and (3) to study the nature of the process of commitment-resistant cell variants including studies of commitment-related gene expression responsible for cell growth and cell cycle control such as the p53 protein gene and others. (M)

Agency
National Institute of Health (NIH)
Institute
National Cancer Institute (NCI)
Type
Research Program Projects (P01)
Project #
5P01CA031768-06
Application #
3093425
Study Section
Cancer Special Program Advisory Committee (CAK)
Project Start
1981-02-01
Project End
1989-01-31
Budget Start
1986-02-01
Budget End
1987-01-31
Support Year
6
Fiscal Year
1986
Total Cost
Indirect Cost
Name
Sloan-Kettering Institute for Cancer Research
Department
Type
DUNS #
064931884
City
New York
State
NY
Country
United States
Zip Code
10065
Lim, L C; Swendeman, S L; Sheffery, M (1992) Molecular cloning of the alpha-globin transcription factor CP2. Mol Cell Biol 12:828-35
Powell, C T; Leng, L; Dong, L et al. (1992) Protein kinase C isozymes epsilon and alpha in murine erythroleukemia cells. Proc Natl Acad Sci U S A 89:147-51
Richon, V M; Rifkind, R A; Marks, P A (1992) Expression and phosphorylation of the retinoblastoma protein during induced differentiation of murine erythroleukemia cells. Cell Growth Differ 3:413-20
Richon, V M; Weich, N; Leng, L et al. (1991) Characteristics of erythroleukemia cells selected for vincristine resistance that have accelerated inducer-mediated differentiation. Proc Natl Acad Sci U S A 88:1666-70
Marks, P A; Rifkind, R A (1991) Differentiating agents in cancer therapy. Cancer Chemother Biol Response Modif 12:291-305
Breslow, R; Jursic, B; Yan, Z F et al. (1991) Potent cytodifferentiating agents related to hexamethylenebisacetamide. Proc Natl Acad Sci U S A 88:5542-6
Marks, P A; Rifkind, R A (1990) Role of differentiation induction in tumor suppression. Immunol Ser 51:201-16
Weich, N; Marks, P A; Rifkind, R A (1990) Relationship between globin mRNA accumulation and commitment to terminal cell differentiation in inducer sensitive and resistant erythroleukemia variants. Blood 76:302-6
Michaeli, J; Lebedev, Y B; Richon, V M et al. (1990) Conversion of differentiation inducer resistance to differentiation inducer sensitivity in erythroleukemia cells. Mol Cell Biol 10:3535-40
Marks, P A; Rifkind, R A (1990) Approaches to more effective induction of cytodifferentiation of transformed cells and potential for cancer treatment. Rinsho Ketsueki 31:401-8

Showing the most recent 10 out of 35 publications